Sangamo Therapeutics, Inc. - SGMO

SEC FilingsOur SGMO Tweets

About Gravity Analytica

Recent News

  • 09.04.2025 - Wells Fargo Health Care Conference
  • 09.03.2025 - Cantor Global Healthcare Conference
  • 06.17.2025 - H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
  • 06.12.2025 - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 05.27.2025 - Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
  • 05.13.2025 - May 13, 2025 - May 17, 2025 : ASGCT Annual Meeting 2025

Recent Filings

  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.13.2025 - 8-K Current report
  • 05.13.2025 - 424B5 Prospectus [Rule 424(b)(5)]
  • 05.13.2025 - FWP Filing under Securities Act Rules 163/433 of free writing prospectuses